Cargando…
Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine
Limited data exist concerning the long-term (≥5 year) survival rates of patients with stage IIIB and IV non-small cell lung carcinoma (NSCLC) receiving chemotherapy. We aimed to determine the long-term results of cisplatin plus third-generation (vinorelbine or gemcitabine) cytotoxic chemotherapy in...
Autores principales: | OZKAYA, SEVKET, FINDIK, SERHAT, DIRICAN, ADEM, ATICI, ATILLA GÜVEN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494120/ https://www.ncbi.nlm.nih.gov/pubmed/23226770 http://dx.doi.org/10.3892/etm.2012.714 |
Ejemplares similares
-
Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
por: Ozkaya, Sevket, et al.
Publicado: (2008) -
A Very Rare Cause of Pleuritic Chest Pain: Bilateral Pleuritis as a First Sign of Familial Mediterranean Fever
por: Ozkaya, Sevket, et al.
Publicado: (2013) -
The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease
por: Ozkaya, Sevket, et al.
Publicado: (2011) -
Diagnostic efficacy of computed tomography-guided transthoracic needle aspiration and biopsy in patients with pulmonary disease
por: Tuna, Tibel, et al.
Publicado: (2013) -
Polyostotic fibrous dysplasia of the ribs: An unusual cause of chest pain and dyspnea
por: Ozkaya, Sevket, et al.
Publicado: (2009)